title: Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study.
abstract: BACKGROUND
  Little is known about the evolution of brain perfusion alterations in patients with major depression, and still less about the changes in functional neuroimage produced by different antidepressant biological treatments.
  
  
  METHODS
  Between January 2001 and December 2003, long-term follow-up frontal brain perfusion was compared in 2 subgroups of elderly patients (>or= 60 years) treated for severe unipolar major depression (DSM-IV): one subgroup of 16 patients administered electroconvulsive therapy, and another of 26 patients receiving pharmacologic treatment. All patients were remitters. A medication-free brain single photon emission computed tomography was performed in baseline conditions and after a minimum period of 12 months of euthymia. Twenty-eight age- and sex-matched healthy controls were also assessed.
  
  
  RESULTS
  No significant differences were found between the 2 subgroups in frontal uptake ratios after a 12-month follow-up period of euthymia. During the acute episode, patients presented significant anterior hypofrontality; 12 months later the hypofrontality had disappeared.
  
  
  CONCLUSIONS
  The long-term evolution of frontal perfusion in elderly major depressives who respond to antidepressant biological treatment is essentially the same in those who receive electroconvulsive therapy and in those who receive medication.
authors.affiliation: Department of Nuclear Medicine, Hospital Clinic, University of Barcelona, Barcelona, Spain. 30739vno@comb.es
authors.forename: Víctor
authors.initials: V
authors.lastname: Navarro
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Gastó
authors.forename: Francisco
authors.initials: F
authors.lastname: Lomeña
authors.forename: José J
authors.initials: JJ
authors.lastname: Mateos
authors.forename: María J
authors.initials: MJ
authors.lastname: Portella
authors.forename: Guillem
authors.initials: G
authors.lastname: Massana
authors.forename: Miguel
authors.initials: M
authors.lastname: Bernardo
authors.forename: Teodoro
authors.initials: T
authors.lastname: Marcos
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy; D003865:Major Depressive Disorder / Q000000981:diagnostic imaging / Q000523:psychology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D005260:Female; D005500:Follow-Up Studies; D005625:Frontal Lobe / Q000098:blood supply* / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012039:Regional Blood Flow; D012720:Severity of Illness Index; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D019690:Technetium Tc 99m Exametazime